Company: STAA
Filing Date: 2025-12-11
Form Type: DEFA14A
Source: 0001193125-25-315272
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-12-11
Form: DEFA14A
Chunk 1
---
 “ward off this well-established private equity firm.” That is patently false. Broadwood is again twisting facts related to STAAR’s engagement with parties during the go-shopprocess, and this is just their latest attempt to derail STAAR’s efforts to maximize value for all stockholders. Yunqi Capital (“Yunqi”) has also re-iteratedthe Broadwood fallacy that there was another “credible buyer,” and suggested that STAAR should address these accusations. STAAR agrees with Yunqi that it is important to set the record straight. The facts are:

| • |     | Nevertheless, STAAR’s CEO responded to FountainVest the very next day, day 22 of the go-shop process, and connected them with STAAR’s advisors at Citi. |

| • |     | On day 23 of the go-shop process, Citi engaged in a discussion with                                                                                                          
 FountainVest and provided it with STAAR’s standard draft nondisclosure agreement (“NDA”). As is customary in a sell-side auction, the draft included a standstill provision. |

| • |     | The draft NDA that STAAR provided FountainVest was the same form provided to other interested parties during the go-shop process. Of the 21 third parties that were contacted during the go-shop, only two requested and signed an NDA. In each case, changes to the form NDA were requested, 
 including modifications to the standstill provision, which STAAR agreed to, and each of those parties received confidential information and management presentations to facilitate their evaluation of STAAR.                                                                                 |

| • |     | Despite outreach by Citi, FountainVest did not return a draft of the NDA for 5 days, sending its                               
 markup (which, among other things, deleted the standstill provision) shortly before midnight on day 28 of the go-shop process. |

| • |     | Within 24 hours thereafter, on day 29 of the go-shop                                                                                                                         
 process, STAAR responded to FountainVest with a revised NDA that accepted FountainVest’s deletion of the standstill. Despite this, FountainVest declined to execute the NDA. |

| • |     | Within hours after STAAR announced the expiration of the go-shop,                                                                                              
 Broadwood issued a press release criticizing the results of the go-shop process and disclosing detailed information regarding STAAR’s process and form of NDA. |

Investors should ask:

| • |     | If FountainVest was a “credible buyer